Keywords: فارماکودینامیک; Alcohol interaction; Ethanol; Almorexant; Orexin; Pharmacokinetics; Pharmacodynamics;
مقالات ISI فارماکودینامیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فارماکودینامیک; Pharmacokinetics; pharmacodynamics; renal replacement therapy; antibiotics; infection; critical illness;
Keywords: فارماکودینامیک; BBB; blood-brain barrier; CAD; Charged Aerosol Detector; CM; chitosan-microsphere; CP; compritol; CTS; cryptotanshinone; DGLC; Double gradient liquid chromatograph; DH-Ppt; dehydrogynated protopanaxatriol; DSS; danshensu; F; bioavailability; FA; ferulic
Keywords: فارماکودینامیک; 17-OHPC; adverse event; biomarker; cervical length; early preterm birth; history of preterm birth; metaanalysis; multiple gestation; pharmacodynamics; progestogens; safety; short cervix; twin gestation
Keywords: فارماکودینامیک; Drug metabolizing enzymes; ontogeny; paediatric pharmacology; pharmacodynamics; pharmacogenetics; pharmacokinetics
Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: Design, rationale, and sample characteristics of the PACIFY randomized trial
Keywords: فارماکودینامیک; Fentanyl; PCI; Platelet inhibition; Ticagrelor; Pharmacokinetics; Pharmacodynamics;
In vitro and in vivo pharmacokinetic and pharmacodynamic study of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent
Keywords: فارماکودینامیک; MBRI-001; Pharmacokinetics; Pharmacodynamics; Combination treatment; Anticancer agent;
Thrombin generation test: A reliable tool to evaluate the pharmacodynamics of vitamin K antagonist rodenticides in rats
Keywords: فارماکودینامیک; CAT; calibrated automated test; ETP; endogenous thrombin potential; F; factor; LT; lag time; PD; pharmacodynamics; PH; peak height; PNrP; pooled normal rat plasma; PPP; platelet poor plasma; PT; prothrombin time; TGT; thrombin generation test; TTP; time t
Pharmacokinetics and pharmacodynamics of intravesical and intravenous TMX-101 and TMX-202 in a F344 rat model
Keywords: فارماکودینامیک; Immune modulator; Imiquimod; Non-muscle-invasive bladder cancer; Pharmacodynamics; Pharmacokinetics; Toll-like receptor;
Phase I/II pharmacokinetic and pharmacodynamic evaluation of two levonorgestrel-only contraceptive patches in a multicenter randomized trial
Keywords: فارماکودینامیک; Contraceptive patch; Levonorgestrel; Cervical mucus; Pharmacodynamics; Ovulation suppression;
Optimization and application of an HPLC method for quantification of inosine-5â²-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients
Keywords: فارماکودینامیک; Mycophenolic acid; Inosine 5â²-monophosphate dehydrogenase; High performance liquid chromatography; Pharmacodynamic biomarker; AEC; area under enzyme activity-time curve; AMP; adenosine monophosphate; AUC; area under the concentration-time curve; BSA; bo
Administration of temozolomide: Comparison of conventional and metronomic chemotherapy regimens
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Modelization; Multi-criteria decision-making; Metronomic chemotherapy;
Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
Keywords: فارماکودینامیک; p-Synephrine; Gliclazide; Diabetes; Pharmacodynamics; Pharmacokinetics;
Herb-drug interaction of Nisha Amalaki and Curcuminoids with metformin in normal and diabetic condition: A disease system approach
Keywords: فارماکودینامیک; NA; Nisha Amalaki; CE; Curcuminoids; MET; metformin; DDI; drug-drug interactions; HDI; herb-drug interactions; CYPs; cytochrome p450 isoenzymes; IS; internal standard; MWR; Male Wistar rats; STZ; streptozotocin; MNC; mononuclear cells; OCT; organic cation
Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy
Keywords: فارماکودینامیک; ACR; albumin-to-creatinine ratio; AUC0-t; area under the curve; BuOH; n-butanol; BUN; blood urea nitrogen; Cmax; peak concentration; C13-NMR; C13-nuclear magnetic resonance; CCr; creatinine clearance rate; CCR2; CCchemkin receptor 2; CDCl3; Deuterotrichlo
Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese Subjects
Keywords: فارماکودینامیک; active metabolite; clopidogrel; CYP2C19; pharmacodynamics; pharmacokinetics; polymorphisms;
Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics
Keywords: فارماکودینامیک; ABC; ATP-binding cassette transporter; ADAR; adenosine deaminase acting on RNA; ADH; alcohol dehydrogenase; AhR; aryl hydrocarbon receptor; AKR; aldo-keto reductase; ALS; amyotrophic lateral sclerosis; AZIN1; antizyme inhibitor 1; AMPA; α-amino-3-hydroxy
Pharmacokinetics and Pharmacodynamics of Nebulized and Intratracheal Milrinone in a Swine Model of Hypercapnia Pulmonary Hypertension
Keywords: فارماکودینامیک; milrinone; pulmonary hypertension; nebulization; intratracheal administration; pharmacokinetics; pharmacodynamics;
Safety, immunogenicity, and clinical outcomes in patients with Morquio A syndrome participating in 2 sequential open-label studies of elosulfase alfa enzyme replacement therapy (MOR-002/MOR-100), representing 5â¯years of treatment
Keywords: فارماکودینامیک; Morquio A; Mucopolysaccharidosis IVA; Long-term extension; Elosulfase alfa; 3MSCT; 3-min stair climb test; 6MWT; 6-min walk test; AE; adverse event; AUC0ât; area under the curve from time 0 to last measurable concentration; AUCinf; area under the curve
Pharmacokinetics and pharmacodynamic effects in koi carp (Cyprinus carpio) following immersion in propofol
Keywords: فارماکودینامیک; fish; immersion; koi carp; pharmacodynamics; pharmacokinetics; propofol;
Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis
Keywords: فارماکودینامیک; Psoriasis; S1P receptor modulator; Modeling; Pharmacokinetics; Pharmacodynamics;
Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives
Keywords: فارماکودینامیک; RORγt; retinoic acid receptor-related orphan receptor-gamma t; EAE; experimental autoimmune encephalomyelitis; BODIPY; boron-dipyrromethene; TR-FRET; time-resolved fluorescence resonance energy transfer; SAR; structure-activity relationship; IFN-γ; inte
Pharmacogenomics in epilepsy
Keywords: فارماکودینامیک; Pharmacokinetics; Pharmacodynamics; Precision medicine; Epilepsy; Drug resistance; Drug response; Adverse drug reactions; Pharmacogenomics;
The G2019S mutation in LRRK2 imparts resiliency to kinase inhibition
Keywords: فارماکودینامیک; Park8; Dardarin; Pharmacodynamics; Pharmacokinetics; Small-molecule inhibitor; LRRK2; Leucine-rich repeat kinase 2; PD; Parkinson disease; ATP; adenosine-tri phosphate; DTT; dithiothreitol; HSC70; Heat-shock cognate 70; Rab; Ras gene from rat brain, or Ra
Influence of Renal Function on the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Non-Vitamin K Antagonist Oral Anticoagulants
Keywords: فارماکودینامیک; AF; atrial fibrillation; BID; twice daily; CKD; chronic kidney disease; CL/F; apparent total clearance after oral administration; CrCL; creatinine clearance; CYP3A4; cytochrome P450 3A4; DVT; deep vein thrombosis; eGFR; estimated glomerular filtration rat
Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia
Keywords: فارماکودینامیک; PDGFR kinase; Type II inhibitor; Kinase inhibitor; CEL; PDGFR; platelet-derived growth factor receptor; RTK; Receptor Tyrosine Kinases; ABL kinase; Abelson kinase; KIT kinase; v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; RTK; receptor ty
Assessment of in vivo efficacy of eravacycline against Enterobacteriaceae exhibiting various resistance mechanisms: a dose-ranging study and pharmacokinetic/pharmacodynamic analysis
Keywords: فارماکودینامیک; Eravacycline; Pharmacodynamics; Tetracycline; Humanised dose;
Soup with or without meatballs: Impact of nutritional factors on the MIC, kill-rates and growth-rates
Keywords: فارماکودینامیک; Meropenem; Pseudomonas aeruginosa ATCC 29853; Hill equation; Emax model; Modelling; MIC; Pharmacodynamics;
Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations
Keywords: فارماکودینامیک; Antibiotic; Pulmonary exacerbation; Pseudomonas aeruginosa; Pharmacodynamics;
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
Keywords: فارماکودینامیک; Leishmania; Efficacy; Pharmacodynamics; Oxaboroles; Aminopyrazoles; Nitroimidazoles;
Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy
Keywords: فارماکودینامیک; Antibiotics; Dosing; Pharmacokinetics; Pharmacodynamics; Renal replacement therapy; Prolonged intermittent renal replacement therapy;
Experimental design and modelling approach to evaluate efficacy of β-lactam/β-lactamase inhibitor combinations
Keywords: فارماکودینامیک; Avibactam; Aztreonam; Ceftazidime; Model; Pharmacodynamics; Pharmacokinetic; Simulation; Translation;
Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system
Keywords: فارماکودینامیک; Pharmacodynamics; Pharmacokinetics; Combination therapy; Hollow fiber infection model system;
Pharmacodynamic and pharmacokinetic characteristics of YMR-65, a tubulin inhibitor, in tumor-bearing mice
Keywords: فارماکودینامیک; UPLC-MS/MS; ultra-performance liquid chromatography-tandem mass spectrometer; IS; internal standard; Cmax; maximum concentration of plasma; t1/2; half-life; AUC; area under the curve; Vd; apparent volume of distribution; MRT; Mean Retention Time; CL; clea
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: AÂ randomized controlled study
Keywords: فارماکودینامیک; Asthma; viral infection; inflammation; Toll-like receptor 3; ACQ7; Asthma Control Questionnaire 7; AE; Adverse event; AUC; Area under the curve; CCSS; Cold and Chest Symptom Scale; CSAS; Cold Symptom Assessment Score; Feno; Fraction of exhaled nitric oxid
Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment
Keywords: فارماکودینامیک; 3Rs; Reduction, Replacement, Refinement; PBPK; physiologically based pharmacokinetic; 2D; two-dimensional; 3D; three-dimensional; HTS; high-throughput screening; IVIVE; in vitro-in vivo extrapolation; ADME; absorption, distribution, metabolism and excreti
Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent
Keywords: فارماکودینامیک; MEAI; Nonlinear; Toxicokinetics; Pharmacodynamics; Aminoindane;
Nucleosidic DNA demethylating epigenetic drugs - A comprehensive review from discovery to clinic
Keywords: فارماکودینامیک; ALL; Acute lymphoblastic leukemia; AML; Acute myeloid leukemia; AUC; Area under the curve; AZA; 5-azacytidine; 5-aza-CdR; 2â²-deoxy-5-azacytidine; 5-aza-CR; 5-azacytidine; AZN; Azanucleosides; BED; Biologically effective dose; BSC; Best supportive care;
Pharmacodynamic activity of fosfomycin simulating urinary concentrations achieved after a single 3-g oral dose versus Escherichia coli using an in vitro model
Keywords: فارماکودینامیک; Resistance; Reduced susceptibility; Pharmacodynamics; Antimicrobial; Fosfomycin;
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy
Keywords: فارماکودینامیک; Therapeutic drug monitoring; TDM; Continuous renal replacement therapy; β-Lactam antibiotic; Pharmacokinetics; Pharmacodynamics;
Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment
Keywords: فارماکودینامیک; Piperacillin; Tazobactam; Peritonitis; Inflammatory bowel disease; Pharmacokinetics; Pharmacodynamics; PIP-TAZ; piperacillin-tazobactam; AUC; area under the drug concentration-time curve; MIC; minimum inhibitory concentration; Cmax; observed maximum conce
Efficacy of anticonvulsant substances in the 6Â Hz seizure test: Comparison of two rodent species
Keywords: فارماکودینامیک; ADD; anticonvulsant drug development; AED; antiepileptic drug; g; grams; Hz; hertz; i.p.; intraperitoneal; LEV; levetiracetam; LTG; lamotrigine; MES; maximal electroconvulsive shock; NMRI; national marine research institute; PD; pharmacodynamics; PHT; phe
Ex vivo antibacterial activity of levofloxacin against Escherichia coli and its pharmacokinetic profile following intravenous and oral administrations in broilers
Keywords: فارماکودینامیک; Levofloxacin; Pharmacokinetics; Pharmacodynamics; Broilers; Escherichia coli;
Original ResearchA phase I study of SAR405838, a novel human double minute 2 (HDM2) antagonist, in patients with solid tumours
Keywords: فارماکودینامیک; De-differentiated liposarcoma; HDM2; MDM2; p53; Pharmacokinetics; Pharmacodynamics; SAR405838; Solid tumours;
Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery
Keywords: فارماکودینامیک; Fc fusion; Single chain Fc; Protein delivery; Human growth hormone; Pharmacokinetics; Pharmacodynamics;
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
Keywords: فارماکودینامیک; Alzheimer's disease; Antibody; Amyloid; Pharmacokinetics; Pharmacodynamics; Ponezumab; PIB; Safety; Tolerability; Anti-drug antibodies;
Controle da hipnose na administração de propofol com base na estratégia de controle não linear
Keywords: فارماکودینامیک; Anestesia de circuito fechado; Controle moderno; Biocontrole; Farmacodinâmica; Farmacocinética; Closedâloop anesthesia; Modern control; Biocontrol; Pharmacodynamics; Pharmacokinetics;
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products
Keywords: فارماکودینامیک; Pharmacodynamics; Pharmacokinetics; Generic antibiotics; Therapeutic equivalence; Antimicrobial resistance; Piperacillin/tazobactam;
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes
Keywords: فارماکودینامیک; Polymyxin B; Meropenem; KPC carbapenemase; Klebsiella pneumoniae; Combination; Pharmacodynamics;
Bioadhesive chitosan-loaded liposomes: A more efficient and higher permeable ocular delivery platform for timolol maleate
Keywords: فارماکودینامیک; Ocular drug delivery; Liposomes; Chitosan; Bioadhesive; Gamma scintigraphic; Pharmacodynamics;